Evaluation of 18 F-fluorothymidine positron emission tomography ([ 18 F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer

Abstract

Background

3'-Deoxy-3'-[¹⁸F]fluorothymidine ([¹⁸F]FLT) PET has limited utility in abdominal imaging due to high physiological hepatic uptake of a tracer. We evaluated [¹⁸F]FLT-PET/CT combined with a temporal-intensity information-based voxel-clustering approach termed kinetic spatial filtering (KSF) to improve tumour visualisation in patients with locally advanced and metastatic gastro-oesophageal cancer and as a marker of early response to chemotherapy.

Dynamic [¹⁸F]FLT-PET/CT data were collected before and 3 weeks post first cycle of chemotherapy. Changes in tumour [¹⁸F]FLT-PET/CT variables were determined. Response was determined on contrast-enhanced CT after three cycles of therapy using RECIST 1.1.

Results

Ten patients were included. Following application of the KSF, visual distinction of all oesophageal and/or gastric tumours was observed in [¹⁸F]FLT-PET images. Among the nine patients available for response evaluation (RECIST 1.1), three patients had responded (partial response) and six patients were non-responders (stable disease). There was a significant association between Ki-67 and all baseline [¹⁸F]FLT-PET parameters. Area under the curve (AUC) from 0 to 1 min was associated with treatment response.

Conclusions

The results of this study indicate that application of the KSF allowed accurate visualisation of both primary and metastatic lesions following imaging with the proliferation marker, [¹⁸F]FLT-PET/CT. However, [¹⁸F]FLT-PET uptake parameters did not correlate with response. Instead, we observe significant changes in tracer delivery following chemotherapy suggesting that further [¹⁸F]FLT-PET/CT studies in this tumour type should be undertaken with caution.

from Cancer via ola Kala on Inoreader http://ift.tt/2ghSGAs
via IFTTT